Literature DB >> 26617796

Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning.

Fang Ma1, Hengchao Liu2, Yong Shen2, Yingjie Zhang1, Shaojun Pan1.   

Abstract

The ischemia-protective mechanism of remote precondition has been a mystery for a long time. Little was known about details of the inter-organ cardio-protective. Microvesicles, also known as microparticles (MPs), are small membrane-vesicles budding from the plasma membrane of cell. Recent studies have indicated MPs to be an important messenger in various biological processes. Our research mainly examined the hypothesis that remote ischemic conditioning can attenuate heart infarction in a rat after they were subjected to 30 min ischemia and 180 min reperfusion (I/R) by MPs. MPs were extracted from three groups of rat: 1) healthy rats, 2) healthy rats that underwent hindlimb ischemia-reperfusion preconditioning (RIPC) immediately, 3) healthy rats that underwent RIPC in 6 hours. Isolated MPs were transfused into rats that had undergone I/R without RIPC. The transfusion of MPs from rats that underwent RIPC immediately resulted in an increase in platelet-derived MPs in blood and reduction in infarction size, confirmed by 2-3-5-triphenyltetrazolium chloride staining. We further observed the contractile function in hearts after they were subjected to different treatments. However, no significant difference was observed in transfusion of MPs from rats that underwent RIPC in 6 hours. RIPC induces an increase in MPs, and platelet-derived MPs may confer at least part of the remote protective effect against cardiac ischemic-reperfusion injury.

Entities:  

Keywords:  Heart Ischemia/reperfusion; microparticles; remote ischemia-reperfusion preconditioning

Mesh:

Year:  2015        PMID: 26617796      PMCID: PMC4637611     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report.

Authors:  Stéphane Robert; Romaric Lacroix; Philippe Poncelet; Karim Harhouri; Tarik Bouriche; Coralie Judicone; Jennifer Wischhusen; Laurent Arnaud; Françoise Dignat-George
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-09       Impact factor: 8.311

2.  Remote ischemic per-conditioning: a novel therapy for acute stroke?

Authors:  Cecil D Hahn; Cedric Manlhiot; Michael R Schmidt; Torsten T Nielsen; Andrew N Redington
Journal:  Stroke       Date:  2011-08-11       Impact factor: 7.914

3.  Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.

Authors:  Robert Flaumenhaft; James R Dilks; Jennifer Richardson; Eva Alden; Sunita R Patel-Hett; Elisabeth Battinelli; Giannoula L Klement; Martha Sola-Visner; Joseph E Italiano
Journal:  Blood       Date:  2008-09-18       Impact factor: 22.113

4.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

Review 5.  The carrying pigeons of the cell: exosomes and their role in infectious diseases caused by human pathogens.

Authors:  Adam Fleming; Gavin Sampey; Myung-Chul Chung; Charles Bailey; Monique L van Hoek; Fatah Kashanchi; Ramin M Hakami
Journal:  Pathog Dis       Date:  2014-02-24       Impact factor: 3.166

6.  Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles.

Authors:  Zoltán Giricz; Zoltán V Varga; Tamás Baranyai; Péter Sipos; Krisztina Pálóczi; Ágnes Kittel; Edit I Buzás; Péter Ferdinandy
Journal:  J Mol Cell Cardiol       Date:  2014-01-16       Impact factor: 5.000

7.  Clearance of platelet microparticles in vivo.

Authors:  A Rank; R Nieuwland; A Crispin; S Grützner; M Iberer; B Toth; R Pihusch
Journal:  Platelets       Date:  2011-01-13       Impact factor: 3.862

Review 8.  Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011 Sep-Dec       Impact factor: 2.457

9.  Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.

Authors:  Fatih Arslan; Ruenn Chai Lai; Mirjam B Smeets; Lars Akeroyd; Andre Choo; Eissa N E Aguor; Leo Timmers; Harold V van Rijen; Pieter A Doevendans; Gerard Pasterkamp; Sai Kiang Lim; Dominique P de Kleijn
Journal:  Stem Cell Res       Date:  2013-01-14       Impact factor: 2.020

10.  Blood volume in the rat.

Authors:  H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more
  14 in total

1.  Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication.

Authors:  Joseph Wider; Vishnu V R Undyala; Peter Whittaker; James Woods; Xuequn Chen; Karin Przyklenk
Journal:  Basic Res Cardiol       Date:  2018-03-09       Impact factor: 17.165

2.  Remote ischemic preconditioning improves tissue oxygenation in a porcine model of controlled hemorrhage without fluid resuscitation.

Authors:  Gal Yaniv; Arik Eisenkraft; Lilach Gavish; Linn Wagnert-Avraham; Dean Nachman; Jacob Megreli; Gil Shimon; Daniel Rimbrot; Ben Simon; Asaf Berman; Matan Cohen; David Kushnir; Ruth Shaylor; Baruch Batzofin; Shimon Firman; Amir Shlaifer; Michael Hartal; Yuval Heled; Elon Glassberg; Yitshak Kreiss; S David Gertz
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

Review 3.  Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis.

Authors:  Lina Badimon; Rosa Suades; Eduardo Fuentes; Iván Palomo; Teresa Padró
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

Review 4.  Organ-Organ Crosstalk and Alcoholic Liver Disease.

Authors:  Lauren G Poole; Christine E Dolin; Gavin E Arteel
Journal:  Biomolecules       Date:  2017-08-16

Review 5.  Platelet-Derived Microvesicles in Cardiovascular Diseases.

Authors:  Maria T K Zaldivia; James D McFadyen; Bock Lim; Xiaowei Wang; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2017-11-21

Review 6.  Exosomes and cardioprotection - A critical analysis.

Authors:  Sean M Davidson; Derek M Yellon
Journal:  Mol Aspects Med       Date:  2017-11-15

7.  Hypoxia preconditioned renal tubular epithelial cell-derived extracellular vesicles alleviate renal ischaemia-reperfusion injury mediated by the HIF-1α/Rab22 pathway and potentially affected by microRNAs.

Authors:  Lei Zhang; Han Liu; Kai Xu; Zhixin Ling; Yeqing Huang; Qiang Hu; Kai Lu; Chunhui Liu; Yiduo Wang; Ning Liu; Xiaowen Zhang; Bin Xu; Jianping Wu; Shuqiu Chen; Guangyuan Zhang; Ming Chen
Journal:  Int J Biol Sci       Date:  2019-05-07       Impact factor: 6.580

Review 8.  Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.

Authors:  Melanie Ziegler; Xiaowei Wang; Karlheinz Peter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

Review 9.  Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration.

Authors:  Andrea Caccioppo; Luca Franchin; Alberto Grosso; Filippo Angelini; Fabrizio D'Ascenzo; Maria Felice Brizzi
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

10.  Evaluation of the cardioprotective potential of extracellular vesicles - a systematic review and meta-analysis.

Authors:  Sebastian Wendt; Andreas Goetzenich; Claudia Goettsch; Christian Stoppe; Christian Bleilevens; Sandra Kraemer; Carina Benstoem
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.